Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
CymaBay Therapeutics Announces Publication of Results From the ENHANCE, Phase 3 Study of Seladelpar in Patients with Primary Biliary Cholangitis (PBC)
CymaBay Therapeutics, a biopharmaceutical company focused on developing and providing access to innovative therapies for […]
XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease
XORTX Therapeutics, a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive […]
Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of […]
Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors
Janux Therapeutics, a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying […]
Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA
Daiichi Sankyo has announced that the United States Food and Drug Administration (FDA) has extended […]
Oblato Announces the First Enrollment in a Phase 1 Clinical Trial for an Oral Formulation of OKN-007 in Recurrent High-Grade Glioma Patients
Oblato, a subsidiary company of HLB Therapeutics in Korea, has announced the first enrollment for […]
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth
Trinity Biotech, a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical […]
Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals
Tesis Biosciences, the leader in targeted genetic sequencing, has announced a new predictive genomic test […]
Nano Pharmaceuticals Labs Partners with PLT Health Solutions to Expand its zümXR Targeted Release Ingredients Globally
PLT Health Solutions announced that it has partnered with Nano Pharmaceuticals Labs to market its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more